Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02029872 · ClinicalTrials.gov registry record · Phase 4
Stop Community MRSA Colonization Among Patients
A Phase 4 study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Phase 4
- Development phase
- 77
- Enrollment target
NCT02029872: Completed Phase 4 study, sponsored by Johns Hopkins University.
NCT02029872 is a Phase 4 study that has completed, run by Johns Hopkins University. The registered enrollment target is 77 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02029872, a Phase 4 study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 77 participants
- Enrollment target
Study Summary
This research is being done to learn more about an approach to remove Methicillin resistant Staphylococcus aureus (MRSA) in patients who are carriers of the bacteria in outpatient settings and among their household members and sexual partners. MRSA is a type of bacteria or germ that can cause bad infections of the skin that can make people very sick. The bacteria have been seen in a high number of persons in the Baltimore area and in hospitals throughout the country. MRSA can be spread from person to person, particularly in homes and among family members and sexual partners. There are three things the investigators hope to learn from this research study: First, the investigators want to find a way to prevent MRSA infections in outpatient settings. By asking questions, the investigators want to look at the things that may increase the risk of having this type of bacteria in you and your family members. Second, the investigators have soaps and oral rinses (Chlorhexidine) and medications (antibiotics; Mupirocin ointment) that have been shown to be effective at removing MRSA. The investigators want to determine if these antibiotics and soaps are best used for everyone in the household or only the individual with known MRSA. Third, as the investigators, we want to learn more about the bacteria by looking at it on the inside. The investigators will do laboratory tests on samples we collect, to learn how MRSA bacteria grow, reproduce and how it develops to behave differently than other types of MRSA bacteria.
Interventions
- DRUG Chlorhexidine gluconate oral rinse
- DRUG Chlorhexidine gluconate soap
- DRUG Mupirocin calcium 2 % ointment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 77 participants |
| Start Date | 2014-01 |
| Est. Completion | 2017-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02029872
The ClinicalTrials.gov registry entry for NCT02029872 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 77 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Chlorhexidine gluconate oral rinse is the first listed.
NCT02029872 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02029872 about?
NCT02029872 is a clinical study titled "Stop Community MRSA Colonization Among Patients". This research is being done to learn more about an approach to remove Methicillin resistant Staphylococcus aureus (MRSA) in patients who are carriers of the bacteria in outpatient settings and among their household members and sexual partners. MRSA is a type of bacteria or germ that can cause bad i...
What is the current status of trial NCT02029872?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 77 participants. The study started on 2014-01. Estimated completion is 2017-03.
What interventions are being tested in trial NCT02029872?
The interventions under investigation include: Chlorhexidine gluconate oral rinse (DRUG), Chlorhexidine gluconate soap (DRUG), Mupirocin calcium 2 % ointment (DRUG).
Who is sponsoring clinical trial NCT02029872?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.